Methotrexate

NDC 0703-3675 · Teva Parenteral Medicines, Inc.

Generic nameMethotrexate

Dosage formINJECTION, SOLUTION

RouteINTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS

Active ingredient(s)METHOTREXATE SODIUM

Strength25 mg/mL

Pharmacologic classFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]

Marketing categoryANDA

Packages

0703-3675-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-3675-01) / 10 mL in 1 VIAL, SINGLE-DOSE

J9260 — Injection, methotrexate sodium, 50 mg Medicare Part B payment limit (ASP + 6%): $2.94

FDA lists these products with the same active ingredient.

0054-4550 — Methotrexate Sodium, 0378-0014 — methotrexate, 0555-0572 — Methotrexate, 0703-3671 — Methotrexate, 0703-3678 — Methotrexate, 16729-486 — Methotrexate, 42291-594 — Methotrexate, 46708-711 — methotrexate, 46708-712 — methotrexate, 46708-730 — METHOTREXATE, 47335-235 — Methotrexate Sodium, 48433-065 — methotrexate, 50090-5457 — Methotrexate, 51079-670 — methotrexate, 51285-366 — Methotrexate, 51285-367 — Methotrexate, 51285-368 — Methotrexate, 51285-369 — Methotrexate, 51407-121 — methotrexate, 55150-510 — METHOTREXATE, +34 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.